| Rank |
Status |
Study |
| 1 |
Recruiting
|
Post Traumatic Stress Among Relatives of Brain-dead, Withdrawal of Life Support, and Sudden Death Patients
| Condition: |
Stress Disorders, Post-Traumatic |
| Intervention: |
Other: IES-R and HDAS scores |
| Outcome Measures: |
IES-R > 37: yes/no; IES-R; HDAS score |
|
| 2 |
Recruiting
|
Comparative Evaluation of IRM and Autopsy in the Evaluation of Intra Uterine Fetal Death
| Condition: |
Spontaneous Intra Uterine Fetal Death |
| Intervention: |
Other: Comparaison between MR and autopsy in the macroscopic evaluation of intra uterine Death. |
| Outcome Measures: |
Recognition of anatomic cerebral structures evaluated by a common grid.; Recognition and mesurement of anatomic thoracic and abdominal structures by a common grid.; Recognition and mesurement of the placenta and umbilical cord.; Comparaison of quality criteria of both exams. |
|
| 3 |
Recruiting
|
Sudden Cardiac Death - Screening Of Risk Factors
| Conditions: |
Sudden Cardiac Death; Cardiomyopathies; Channelopathies |
| Intervention: |
Other: ECG and survey screening |
| Outcome Measures: |
Type 1 electrocardiogram; Clinical History - Red Flag; all-cause mortality; Cardiovascular Death |
|
| 4 |
Not yet recruiting
|
Study of Paced QRS Duration as a Marker of Sudden Cardiac Death
| Condition: |
Sudden Cardiac Death |
| Intervention: |
|
| Outcome Measure: |
Sudden Cardiac Death |
|
| 5 |
Recruiting
|
Vest Prevention of Early Sudden Death Trial and VEST Registry
| Conditions: |
Myocardial Infarction; Ventricular Dysfunction; Sudden Death; Ventricular Tachycardia; Ventricular Fibrillation |
| Intervention: |
Device: wearable defibrillator |
| Outcome Measures: |
Sudden Death mortality; Cardiovascular, all-cause, and other cause specific mortality; incidence of ventricular arrhythmias; adverse events attributable to wearable defibrillator use; compliance with wearable defibrillator use |
|
| 6 |
Recruiting
|
Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk
| Condition: |
Sudden Cardiac Death |
| Intervention: |
|
| Outcome Measures: |
sudden cardiac Death; cardiovascular Death; appropriate ICD discharge; composite sudden cardiac Death and appropriate ICD discharge; heart failure admission |
|
| 7 |
Recruiting
|
Epidemiology of Sudden Death in Cameroon
| Condition: |
Cardiovascular Diseases |
| Intervention: |
|
| Outcome Measure: |
Sudden Death, either cardiac or non-cardiac origin |
|
| 8 |
Recruiting
|
Inflammation, Cardiac Sympathetic Innervation, and Arrhythmic Sudden Death
| Conditions: |
Ischemic Cardiomyopathy; Dilated Cardiomyopathy; Inflammation; Sudden Cardiac Death |
| Intervention: |
|
| Outcome Measures: |
Determine if inflammation is associated with abnormal cardiac sympathetic innervation in patients enrolled in the PROSE-ICD study.; Determine if inflammation, measured by IL-6, is associated with abnormal cardiac sympathetic innervation, measured by MIBG imaging; Examine the combination of CRP and MIBG to predict ICD therapies in PROSE-ICD; Compare several MIBG imaging metrics of sympathetic innervation, in addition to the late H/M ratio, including the early H/M ratio and the MIBG washout rate, in regards to their association with biomarkers of inflammation (CRP and IL-6). |
|
| 9 |
Unknown †
|
Do Pacifiers Protect From Sudden Infant Death Syndrome (SIDS) Through an Increase in Upper Airway Patency?
| Condition: |
Sudden Infant Death |
| Intervention: |
|
| Outcome Measure: |
Upper airway caliber and patency |
|
| 10 |
Recruiting
|
Clinical Registry on Sudden Death Primary Prevention at Latin America
| Conditions: |
Myocardial Infarction; Sudden Death |
| Intervention: |
Procedure: Implantable Cardio Defibrillator (ICD), |
| Outcome Measures: |
Prevalence of patients with MADIT, MADIT II and MUST at Latin American countries; Study incidence of Arrhythmic mortality and serious arrhythmic events, evaluated through remote monitoring |
|
| 11 |
Recruiting
|
Computed Tomography Angiography to Brain Death Assessment
| Condition: |
Brain Death |
| Intervention: |
|
| Outcome Measure: |
Assess the presence or absence of contrast medium filling of the intracranial vessels in comatose patients. |
|
| 12 |
Not yet recruiting
|
Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
| Conditions: |
Chagas Cardiomyopathy; Non-sustained Ventricular Tachycardia; At Least 10 Points in Rassi Risk Score for Death |
| Interventions: |
Procedure: ICD implantation; Drug: amiodarone hydrochloride |
| Outcome Measures: |
all cause mortality; Cardiac mortality; Sudden cardiac Death; Worsening heart failure warranting hospitalization; Need for cardiac stimulation in the ICD arm; Need for pacemaker implantation in the amiodarone therapy arm |
|
| 13 |
Recruiting
|
MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction
| Condition: |
Myocardial Infarction |
| Intervention: |
Genetic: Blood sample |
| Outcome Measure: |
Correlation phenotype/genotype of sudden Death at the acute phase of myocardial infarct. |
|
| 14 |
Recruiting
|
Using Ongoing Newborn Intervention Trials to Obtain Additional Data Critical to Maternal, Fetal and Newborn Health in a Harmonized Way
| Conditions: |
Maternal Deaths; Neonatal Deaths; Still Births |
| Intervention: |
Other: This is an observational study being conducted as a substudy of antoher trial. |
| Outcome Measures: |
Burden of maternal and neonatal Death and still births; Timing of maternal and neonatal Death and still births; Causes of maternal and neonatal Death and still births |
|
| 15 |
Recruiting
|
Deceased Donor Biomarkers and Recipient Outcomes
| Conditions: |
Deceased Donor Kidney Transplant; Acute Kidney Injury; Delayed Graft Function; End Stage Renal Disease; Graft Failure |
| Intervention: |
|
| Outcome Measures: |
Delayed Graft Function; Death-Censored Graft Failure; Graft Function |
|
| 16 |
Unknown †
|
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
| Conditions: |
Heart Failure, Congestive; Death, Sudden, Cardiac; Arrhythmia; Cardiomyopathies |
| Intervention: |
|
| Outcome Measures: |
Arrhythmic Sudden Death defined as a shock from the ICD for rapid VT or VF or a ventricular arrhythmia not corrected by the ICD; All cause mortality, CV mortality, heart transplant, ICD explantation |
|
| 17 |
Recruiting
|
Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
| Conditions: |
Refractory Epilepsy; Arrhythmia; Sudden Death |
| Intervention: |
Device: Medtronic REVEAL |
| Outcome Measure: |
|
|
| 18 |
Recruiting
|
Left Ventricular Structural Predictors of Sudden Cardiac Death
| Conditions: |
Ischemic Cardiomyopathy; Nonischemic Cardiomyopathy |
| Intervention: |
|
| Outcome Measures: |
Composite SCD outcomes; Composite cardiac outcomes |
|
| 19 |
Recruiting
|
Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation
| Conditions: |
Deceased Donor Kidney Transplantation; Living Donor Kidney Transplantation |
| Intervention: |
Procedure: kidney transplantation, living or deceased donor |
| Outcome Measures: |
delayed graft function as defined by dialysis requirements within one week after transplantation; delayed graft function as defined by urine output less than1200 ml during first day after transplantation; delayed graft function as defined by serum creatinine decrease less than 10% during 48 hours after transplantation; delayed graft function as defined by creatinine greater than 2.5 mg/dL at ten days after transplantation; delayed graft function as defined by creatinine clearance less than 10 ml/min/1.73m2 during 24 hours after transplantation; delayed graft function as defined by creatinine did not decrease less than preoperative value |
|
| 20 |
Unknown †
|
End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)
| Conditions: |
Chronic Obstructive Pulmonary Disease; End-of-Life Fear; Fear About Death and Dying; Depression |
| Intervention: |
Behavioral: A brief psycho-educational intervention |
| Outcome Measures: |
Self-reported semi-structured interview about the fear of Death and dying, needs and wishes at the end-of-life in patients with severe COPD; St. George's Respiratory Questionnaire (SGRQ); Short Form Health Survey (Fragebogen zum allgemeinen Gesundheitszustand, SF-36); Euroqol (EQ); Patient Health Questionnaire (PHQ); Hospital Anxiety and Depression Scale (HADS); Borg Scale; Diffusion capacity (DLCO); Blood gas analysis (BGA); Bodyplethysmographs; Bio-Impedance-Analysis (BIA); 6-Minute Walk Distance (6 MWD); Body Mass Index (BMI); Blood tests; Multidimensional assessment of attitudes toward Death and dying (Fragebogeninventar zur mehrdimensionalen Erfassung des Erlebens gegenüber Sterben und Tod, FIMEST); COPD- Anxiety -Questionnaire (COPD-Angst-Fragebogen, CAF); COPD- Disability- Index (CDI); Differences in COPD admission rates, functional impairment, quality of life and end-of-life fear after treatment |
|
